Trademark: 79148927
Word
DMBIO Y
Status Date
Friday, July 2, 2021
Registration Number
4654830
Registration Date
Tuesday, December 16, 2014
Filing Date
Thursday, December 19, 2013
Published for Opposition
Tuesday, September 30, 2014
Cancellation Date
Friday, July 2, 2021
5 Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer
42 Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceutical products
The mark consists of the wording "DMBIO Y". The letter "D" is in blue, the letter "M" is in red, and the letters "BIO" are in grey. The letter "Y" is to the upper right of "DMBIO" in the colors red, blue and grey.
The color(s) blue, red and grey is/are claimed as a feature of the mark.
May 16, 2023
Final Decision Transaction Processed By Ib
Jan 24, 2023
Generic Madrid Transaction Sent To Ib
Jan 24, 2023
Invalidation Reviewed - No Action Required By Office
Jan 24, 2023
Generic Madrid Transaction Created
May 30, 2022
Final Decision Transaction Processed By Ib
Mar 2, 2022
Total Invalidation Of Reg Ext Protection Created
Aug 29, 2021
Notification Processed By Ib
Jul 11, 2021
Refusal Processed By Ib
Jul 2, 2021
Cancelled Section 71
Dec 16, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 9, 2017
Change Of Owner Received From Ib
May 22, 2015
Final Decision Transaction Processed By Ib
May 7, 2015
Final Disposition Notice Sent To Ib
May 7, 2015
Final Disposition Processed
Mar 16, 2015
Final Disposition Notice Created, To Be Sent To Ib
Dec 16, 2014
Registered-Principal Register
Sep 30, 2014
Official Gazette Publication Confirmation E-Mailed
Sep 30, 2014
Published For Opposition
Sep 10, 2014
Notification Of Notice Of Publication E-Mailed
Aug 26, 2014
Law Office Publication Review Completed
Aug 21, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 21, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 20, 2014
Assigned To Lie
Aug 16, 2014
Refusal Processed By Ib
Aug 12, 2014
Approved For Pub - Principal Register
Aug 11, 2014
Teas/Email Correspondence Entered
Aug 11, 2014
Correspondence Received In Law Office
Aug 11, 2014
Teas Response To Office Action Received
Jul 25, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Jul 25, 2014
Refusal Processed By Mpu
Jul 22, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Jul 22, 2014
Application Filing Receipt Mailed
Jul 21, 2014
Non-Final Action Written
Jul 16, 2014
Assigned To Examiner
Jul 16, 2014
New Application Office Supplied Data Entered
Jul 14, 2014
Limitation From Original Application Entered
Jul 11, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
